Literature DB >> 17206620

Y-position cysteine substitution in type I collagen (alpha1(I) R888C/p.R1066C) is associated with osteogenesis imperfecta/Ehlers-Danlos syndrome phenotype.

Wayne A Cabral1, Elena Makareeva, Anne D Letocha, Nina Scribanu, Andrzej Fertala, Andrzej Steplewski, Douglas R Keene, Anton V Persikov, Sergey Leikin, Joan C Marini.   

Abstract

The most common mutations in type I collagen causing types II-IV osteogenesis imperfecta (OI) result in substitution for glycine in a Gly-Xaa-Yaa triplet by another amino acid. We delineated a Y-position substitution in a small pedigree with a combined OI/Ehlers-Danlos Syndrome (EDS) phenotype, characterized by moderately decreased DEXA z-score (-1.3 to -2.6), long bone fractures, and large-joint hyperextensibility. Affected individuals have an alpha1(I)R888C (p.R1066C) substitution in one COL1A1 allele. Polyacrylamide gel electrophoresis (PAGE) of [(3)H]-proline labeled steady-state collagen reveals slight overmodification of the alpha1(I) monomer band, much less than expected for a substitution of a neighboring glycine residue, and a faint alpha1(I) dimer. Dimers form in about 10% of proband type I collagen. Dimer formation is inefficient compared to a possible 25%, probably because the SH-side chains have less proximity in this Y-position than when substituting for a glycine. Theoretical stability calculations, differential scanning calorimetry (DSC) thermograms, and thermal denaturation curves showed only weak local destabilization from the Y-position substitution in one or two chains of a collagen helix, but greater destabilization is seen in collagen containing dimers. Y-position collagen dimers cause kinking of the helix, resulting in a register shift that is propagated the full length of the helix and causes resistance to procollagen processing by N-proteinase. Collagen containing the Y-position substitution is incorporated into matrix deposited in culture, including immaturely and maturely cross-linked fractions. In vivo, proband dermal fibrils have decreased density and increased diameter compared to controls, with occasional aggregate formation. This report on Y-position substitutions in type I collagen extends the range of phenotypes caused by nonglycine substitutions and shows that, similar to X- and Y-position substitutions in types II and III collagen, the phenotypes resulting from nonglycine substitutions in type I collagen are distinct from those caused by glycine substitutions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17206620     DOI: 10.1002/humu.20456

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  15 in total

1.  Collagen fibril formation. A new target to limit fibrosis.

Authors:  Hye Jin Chung; Andrzej Steplewski; Kee Yang Chung; Jouni Uitto; Andrzej Fertala
Journal:  J Biol Chem       Date:  2008-07-23       Impact factor: 5.157

2.  Aegyptin displays high-affinity for the von Willebrand factor binding site (RGQOGVMGF) in collagen and inhibits carotid thrombus formation in vivo.

Authors:  Eric Calvo; Fuyuki Tokumasu; Daniella M Mizurini; Peter McPhie; David L Narum; José Marcos C Ribeiro; Robson Q Monteiro; Ivo M B Francischetti
Journal:  FEBS J       Date:  2009-12-15       Impact factor: 5.542

3.  Candidate cell and matrix interaction domains on the collagen fibril, the predominant protein of vertebrates.

Authors:  Shawn M Sweeney; Joseph P Orgel; Andrzej Fertala; Jon D McAuliffe; Kevin R Turner; Gloria A Di Lullo; Steven Chen; Olga Antipova; Shiamalee Perumal; Leena Ala-Kokko; Antonella Forlino; Wayne A Cabral; Aileen M Barnes; Joan C Marini; James D San Antonio
Journal:  J Biol Chem       Date:  2008-05-15       Impact factor: 5.157

Review 4.  New perspectives on osteogenesis imperfecta.

Authors:  Antonella Forlino; Wayne A Cabral; Aileen M Barnes; Joan C Marini
Journal:  Nat Rev Endocrinol       Date:  2011-06-14       Impact factor: 43.330

5.  Prolyl 3-hydroxylase 1 null mice display abnormalities in fibrillar collagen-rich tissues such as tendons, skin, and bones.

Authors:  Janice A Vranka; Elena Pokidysheva; Lauren Hayashi; Keith Zientek; Kazunori Mizuno; Yoshihiro Ishikawa; Kerry Maddox; Sara Tufa; Douglas R Keene; Robert Klein; Hans Peter Bächinger
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

Review 6.  The Ehlers-Danlos syndromes.

Authors:  Fransiska Malfait; Marco Castori; Clair A Francomano; Cecilia Giunta; Tomoki Kosho; Peter H Byers
Journal:  Nat Rev Dis Primers       Date:  2020-07-30       Impact factor: 52.329

7.  Osteogenesis imperfecta type III/Ehlers-Danlos overlap syndrome in a Chinese man.

Authors:  Yanqin Lu; Yanzhou Wang; Frank Rauch; Hu Li; Yao Zhang; Naixiang Zhai; Jian Zhang; Xiuzhi Ren; Jinxiang Han
Journal:  Intractable Rare Dis Res       Date:  2018-02

8.  Heterozygous mutation of c.3521C>T in COL1A1 may cause mild osteogenesis imperfecta/Ehlers-Danlos syndrome in a Chinese family.

Authors:  Xianlong Shi; Yanqin Lu; Yanzhou Wang; Yu-Ang Zhang; Yuanwei Teng; Wanshui Han; Zhenzhong Han; Tianyou Li; Mei Chen; Junlong Liu; Fengling Fang; Conghui Dou; Xiuzhi Ren; Jinxiang Han
Journal:  Intractable Rare Dis Res       Date:  2015-02

Review 9.  Collagen misfolding mutations: the contribution of the unfolded protein response to the molecular pathology.

Authors:  John F Bateman; Matthew D Shoulders; Shireen R Lamandé
Journal:  Connect Tissue Res       Date:  2022-02-26       Impact factor: 3.417

10.  Kuskokwim syndrome, a recessive congenital contracture disorder, extends the phenotype of FKBP10 mutations.

Authors:  Aileen M Barnes; Geraldine Duncan; Maryann Weis; William Paton; Wayne A Cabral; Edward L Mertz; Elena Makareeva; Michael J Gambello; Felicitas L Lacbawan; Sergey Leikin; Andrzej Fertala; David R Eyre; Sherri J Bale; Joan C Marini
Journal:  Hum Mutat       Date:  2013-07-08       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.